Takhzyro 150 MG

Ended Awarded Last action

Contract number
36C24526N0839
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Brooks, KY 40109, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$38,360
Original award $38,360

About this award

Veterans Integrated Service Network 5 issued a BPA call to Takeda Pharmaceuticals America, Inc. for TAKHZYRO 150 MG with a ceiling value of $38,360.10 and an award date of August 27, 2026.

The call is issued under a Blanket Purchase Agreement with the VA National Acquisition Center for ICLUSIG supply. Place of performance is Brooks, Kentucky. The ultimate completion date is September 1, 2026. This is a firm fixed price pharmaceutical commodity order for specialty oncology treatment, reflecting Takeda's core federal business of supplying targeted cancer therapies to VA medical facilities across multiple VISNs.

Quick answers

Who was awarded contract 36C24526N0839?

36C24526N0839 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 27, 2026.

How much is contract 36C24526N0839 worth?

The government has obligated $0 on 36C24526N0839.

Is contract 36C24526N0839 an order under another contract?

Yes. 36C24526N0839 is a BPA call under 36F79726D031E-36E79726A0012, a blanket purchase agreement.

Was contract 36C24526N0839 competed?

The extent of competition for 36C24526N0839 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award